Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hay

Showing results (421-430 of 653) with videos related to

Pageof 66
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2012
Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humansMatthias Hoch, Justin L Hay, Petra Hoever, et al.
European Journal of Pain (London, England)|February 23, 2019
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugsPieter S Siebenga, Guido van Amerongen, Pieter Okkerse, et al.
Cell Discovery|July 28, 2016
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.
Endocrinology|September 21, 2001
Oxyntomodulin inhibits food intake in the ratC L Dakin, I Gunn, C J Small, et al.
ACS Pharmacology & Translational Science|January 19, 2023
Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor PharmacologyTyla I Alexander, Zoe Tasma, Andrew Siow, et al.
British Journal of Pharmacology|October 16, 2013
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activationDebbie L Hay, Paul W R Harris, Renata Kowalczyk, et al.
Journal of Pain and Symptom Management|November 14, 2017
What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response ScalesThomas M Atkinson, Jennifer L Hay, Amylou C Dueck, et al.
JMIR Research Protocols|April 30, 2026
Combining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility TrialMargaret Sala, Corey Roos, Dante Ascarrunz, et al.
Psycho-Oncology|March 28, 2024
Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patientsJennifer L Hay, Yelena Wu, Elizabeth Schofield, et al.
Journal of Psychopharmacology (Oxford, England)|September 28, 2018
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in ratsGracie L Hay, Sarah J Baracz, Nicholas A Everett, et al.
Pageof 66

Showing results (421-430 of 653) with videos related to

Sort By:
Pageof 66
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2012
Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humansMatthias Hoch, Justin L Hay, Petra Hoever, et al.
European Journal of Pain (London, England)|February 23, 2019
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugsPieter S Siebenga, Guido van Amerongen, Pieter Okkerse, et al.
Cell Discovery|July 28, 2016
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.
Endocrinology|September 21, 2001
Oxyntomodulin inhibits food intake in the ratC L Dakin, I Gunn, C J Small, et al.
ACS Pharmacology & Translational Science|January 19, 2023
Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor PharmacologyTyla I Alexander, Zoe Tasma, Andrew Siow, et al.
British Journal of Pharmacology|October 16, 2013
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activationDebbie L Hay, Paul W R Harris, Renata Kowalczyk, et al.
Journal of Pain and Symptom Management|November 14, 2017
What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response ScalesThomas M Atkinson, Jennifer L Hay, Amylou C Dueck, et al.
JMIR Research Protocols|April 30, 2026
Combining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility TrialMargaret Sala, Corey Roos, Dante Ascarrunz, et al.
Psycho-Oncology|March 28, 2024
Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patientsJennifer L Hay, Yelena Wu, Elizabeth Schofield, et al.
Journal of Psychopharmacology (Oxford, England)|September 28, 2018
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in ratsGracie L Hay, Sarah J Baracz, Nicholas A Everett, et al.
Pageof 66